Is Do-Si-Dos Indica, Sativa, or Hybrid?

Do-Si-Dos is classified as a indica-dominant hybrid strain.

What terpenes are in Do-Si-Dos?

The dominant terpenes in Do-Si-Dos are Limonene, Caryophyllene, Linalool.

What effects does Do-Si-Dos produce?

Do-Si-Dos is associated with these effects: relaxing, pain, euphoric, sleep.

What is the THC content of Do-Si-Dos?

Do-Si-Dos typically has a THC range of 19-30%.

What is the lineage of Do-Si-Dos?

Do-Si-Dos is descended from OGKB (Girl Scout Cookies Bx) x Face Off OG.

Do-Si-Dos

indica-dominant hybridTHC 19-30%

Lineage: OGKB (Girl Scout Cookies Bx) x Face Off OG

Sweet and earthy with floral notes and a cool minty finish. Expect an initial cerebral lift that melts into full-body relaxation—great for evening use or winding down. A Cookies genetics staple that delivers potent effects.

Dominant Terpenes

Limonene

uplifting · citrus · energising

Caryophyllene

anti-inflammatory · spicy · peppery

Linalool

calming · floral · stress-relief

Effect Profile

Terpene Science

What this strain's terpenes mechanistically point toward — preclinical associations, not medical claims.

Terpene richness: average≈1.04% total

Typical is ~1.5% total terpenes by weight.

Based on its terpene profile, Do-Si-Dos is mechanistically associated with body comfort, relaxing, and euphoric. These are preclinical terpene associations, not medical claims.

Body Comfort

Relaxing

Euphoric

Intimacy

Social

Creative

Focus

Sleep

Appetite

Energizing

leans towardleans away0–100 mechanistic score

Terpene mix — estimated from the lab library

Limonene 28%Caryophyllene 21%Linalool 15%Myrcene 13%Pinene 12%Other 11%

Each % is a terpene's share of the mix. ≈1.04% total terpenes by weight.

What these terpenes drive — hover to explore

supportsworks againstthickness = strength of the link

Percentages are library estimates for this strain (Grade B), not a lab test of your specific product. Relationships come from Matchleaf's terpene–effect model. This is the mechanistic terpene reasoning — associations from preclinical research, not medical claims.